Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of Turoctocog Alfa in Indian Hemophilia A Patients
NCT03449342Phase 4Completed
- Sponsor
- Novo Nordisk
- Start
- Mar 2018
- Primary completion
- Mar 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of turoctocog alfa in hemophilia A, sponsored by Novo Nordisk. Started Mar 2018; status: completed.
02
Drugs
turoctocog alfa
03
Conditions
hemophilia A
Beyond the preview
Go deeper on NCT03449342.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03449342.